학술논문
Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV 1.7
Document Type
Article
Author
Swain, N.A.; Brown, A.D.; Butt, R.P.; Storer, R.I.; Pike, A.; Bechle, B.M.; Beaudoin, S.; Chapman, M.L.; Johnson, M.S.; Lin, Z.; Markworth, C.J.; Marron, B.E.; Printzenhoff, D.; Reister, S.M.; West, C.W.; Batchelor, D.; Bradley, P.A.; Brown, B.; Butcher, K.J.; Denton, S.; Ellis, D.; Galan, S.R.G.; Gaulier, S.M.; Greener, B.S.; De Groot, M.J.; Glossop, M.S.; Hannam, J.; Millan, D.S.; Nakagawa, S.; Rawson, D.J.; Ransley, S.J.; Sasaki, K.; Stupple, P.A.; Gurrell, I.K.
Source
In: Journal of Medicinal Chemistry . (Journal of Medicinal Chemistry, 24 August 2017, 60(16):7029-7042)
Subject
Language
English
ISSN
15204804
00222623
00222623